| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Pedro G Vásquez-Ocmín, Guillaume Marti, Maxime Bonhomme, Fabienne Mathis, Sylvie Fournier, Stéphane Bertani, Alexandre Maciu. Cannabinoids vs. whole metabolome: Relevance of cannabinomics in analyzing Cannabis varieties. Analytica chimica acta. vol 1184. 2021-10-12. PMID:34625242. |
cannabinoids vs. whole metabolome: relevance of cannabinomics in analyzing cannabis varieties. |
2021-10-12 |
2023-08-13 |
Not clear |
| Mariia Zaiachuk, Nazar Pryimak, Olga Kovalchuk, Igor Kovalchu. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy. Frontiers in medicine. vol 8. 2021-10-12. PMID:34631734. |
cannabinoids, medical cannabis, and colorectal cancer immunotherapy. |
2021-10-12 |
2023-08-13 |
Not clear |
| Florence Thibaut, Margret R Hoeh. Cannabinoids: for better and for worse
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162763. |
thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. |
2021-10-11 |
2023-08-13 |
Not clear |
| Marc-Antoine Croc. History of cannabis and the endocannabinoid system
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162765. |
history of cannabis and the endocannabinoid system
. |
2021-10-11 |
2023-08-13 |
Not clear |
| Marc-Antoine Croc. History of cannabis and the endocannabinoid system
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162765. |
this article retraces the story of cannabis from the earliest contacts of humans with the plant to its subsequent global expansion, its medicinal uses, and the discovery of the endocannabinoid system in the 20 |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
this brief report covers recent advances in cannabis and cannabinoid regulation and drug approval. |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
the popularity of cannabis and cannabinoid products continues to rise, and these products are available for the majority of the population in the united states to purchase as easily as alcohol. |
2021-10-11 |
2023-08-13 |
Not clear |
| Jahan Marc. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report
. Dialogues in clinical neuroscience. vol 22. issue 3. 2021-10-11. PMID:33162772. |
multiple pathways for market approval would protect public health, whether the public is using cannabis and cannabinoids as a medicine, a wellness product, or as a recreational substance.
. |
2021-10-11 |
2023-08-13 |
Not clear |
| Veronika Kondev, Nathan Winters, Sachin Pate. Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches. International review of neurobiology. vol 157. 2021-10-11. PMID:33648669. |
furthermore, endocannabinoid deficiency states, either pre-existing or induced by trauma exposure, could provide explanatory insights into the high rates of comorbid cannabis use in patients with ptsd. |
2021-10-11 |
2023-08-13 |
Not clear |
| A A A Putri Laksmidewi, Andreas Soejitn. Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors. Journal of neural transmission (Vienna, Austria : 1996). vol 128. issue 5. 2021-10-11. PMID:33712975. |
endocannabinoid system (ecs) has been identified ever since cannabinoid, an active substance of cannabis, was known to interact with endogenous cannabinoid (endocannabinoid/ecb) receptors. |
2021-10-11 |
2023-08-13 |
human |
| H V Kosiakova, S A Chumak, A G Berdyshev, I Ya Pinchuk, N M Hula, A A Chuma. RADIATION DAMAGE OF THE NERVOUS SYSTEM AND ENDOCANABINOIDS. Problemy radiatsiinoi medytsyny ta radiobiolohii. vol 25. 2021-10-08. PMID:33361830. |
the participation of the endocannabinoid system in ensuring homeostasis andpathology formation, potential possibilities of using cannabis drugs, agonists and antagonists of endocannabinoidreceptors for the treatment of early and long-term effects of radiation are considered. |
2021-10-08 |
2023-08-13 |
Not clear |
| Brady Fleshman, Kim Kaise. Cannabinoid Hyperemesis Syndrome in an Athlete. Journal of the American Board of Family Medicine : JABFM. vol 34. issue 4. 2021-10-08. PMID:34312273. |
cannabinoid hyperemesis syndrome (chs) is 1 outcome of chronic cannabis use, which presents as cyclic intractable vomiting that can be temporarily relieved with hot baths or showers. |
2021-10-08 |
2023-08-13 |
Not clear |
| Cody W Kowalski, Forrest J Ragozzino, Jonathan E M Lindberg, BreeAnne Peterson, Janelle M Lugo, Ryan J McLaughlin, James H Peter. Cannabidiol activation of vagal afferent neurons requires TRPA1. Journal of neurophysiology. vol 124. issue 5. 2021-10-07. PMID:32965166. |
the diverse therapeutic effects of electrical vagus nerve stimulation also result from administration of the nonpsychotropic cannabinoid, cannabidiol (cbd); however, the direct effects of cbd on vagal afferent signaling remain unknown. |
2021-10-07 |
2023-08-13 |
mouse |
| Anne K Schlag, Chandni Hindocha, Rayyan Zafar, David J Nutt, H Valerie Curra. Cannabis based medicines and cannabis dependence: A critical review of issues and evidence. Journal of psychopharmacology (Oxford, England). vol 35. issue 7. 2021-10-07. PMID:33593117. |
we focus on the main issues related to medical cannabis and dependence, including the importance of dose, potency, cannabinoid content, pharmacokinetics and route of administration, frequency of use, as well as set and setting. |
2021-10-07 |
2023-08-13 |
Not clear |
| Justin E LaVigne, Ryan Hecksel, Attila Keresztes, John M Streiche. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific reports. vol 11. issue 1. 2021-10-06. PMID:33859287. |
cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. |
2021-10-06 |
2023-08-13 |
mouse |
| Justin E LaVigne, Ryan Hecksel, Attila Keresztes, John M Streiche. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific reports. vol 11. issue 1. 2021-10-06. PMID:33859287. |
limited evidence has suggested that terpenes found in cannabis sativa are analgesic, and could produce an "entourage effect" whereby they modulate cannabinoids to result in improved outcomes. |
2021-10-06 |
2023-08-13 |
mouse |
| Justin E LaVigne, Ryan Hecksel, Attila Keresztes, John M Streiche. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific reports. vol 11. issue 1. 2021-10-06. PMID:33859287. |
we thus investigated cannabis sativa terpenes alone and with the cannabinoid agonist win55,212 using in vitro and in vivo approaches. |
2021-10-06 |
2023-08-13 |
mouse |
| Justin E LaVigne, Ryan Hecksel, Attila Keresztes, John M Streiche. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific reports. vol 11. issue 1. 2021-10-06. PMID:33859287. |
our findings suggest that these cannabis terpenes are multifunctional cannabimimetic ligands that provide conceptual support for the entourage effect hypothesis and could be used to enhance the therapeutic properties of cannabinoids. |
2021-10-06 |
2023-08-13 |
mouse |
| Ava Mason, Musa Sami, Caitlin Notley, Sagnik Bhattacharyy. Are researchers getting the terms used to denote different types of recreational cannabis right?-a user perspective. Journal of cannabis research. vol 3. issue 1. 2021-10-06. PMID:33926566. |
current categorisation in research focuses on the two main cannabinoids: delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); and two different species of cannabis: indica and sativa. |
2021-10-06 |
2023-08-13 |
human |
| Maya R Jacobson, Jeremy J Watts, Tania Da Silva, Rachel F Tyndale, Pablo M Rusjan, Sylvain Houle, Alan A Wilson, Ruth A Ross, Isabelle Boileau, Romina Mizrah. Fatty acid amide hydrolase is lower in young cannabis users. Addiction biology. vol 26. issue 1. 2021-10-05. PMID:31960544. |
we have recently shown that levels of fatty acid amide hydrolase (faah), the enzyme that metabolizes the endocannabinoid anandamide, are lower in the brains of adult cannabis users (cus) (34 ± 11 years of age), tested during early abstinence. |
2021-10-05 |
2023-08-13 |
human |